Public consultations

---

24 Oct 2024 Consultation on corrections to the CDE Technical Guidance

• Consultative Document: Harmonisation of Critical OTC Derivatives Data Elements (Other than UTI and UPI) - Revised CDE Technical Guidance (Version 4) Consultative Document
  • Response to public consultation (JBA)
  • Response to public consultation (DSB)
  • Response to public consultation (DTI)
  • Response to public consultation (EVIA)
  • Response to public consultation (Bloomberg)
  • Response to public consultation (ISDA)
  • Response to public consultation (KOR)
  • Response to public consultation (ASC)
• Final Document in Dec 2025: Harmonisation of critical OTC derivatives data elements (other than UTI and UPI) - Revised CDE Technical Guidance (Version 4)

---

6 Sep 2022 Consultation on corrections to the CDE Technical Guidance

• Consultative Document: Harmonisation of critical OTC derivatives data elements (other than UTI and UPI)- Revised CDE Technical Guidance (version 3) Consultative Document
  • Response to public consultation (DSB)
  • Response to public consultation (DTCC)
  • Response to public consultation (ISDA)
  • Response to public consultation (KOR Financial)
• Final Document in Sept 2023: Harmonisation of critical OTC derivatives data elements (other than UTI and UPI) - Revised CDE Technical Guidance (version 3)

---

5 May 2021 Consultation on corrections to the CDE Technical Guidance

• Consultative Document: Harmonisation of critical OTC derivatives data elements (other than UTI and UPI) - Revised CDE Technical Guidance (version 2) Consultative Document
  • Response to public consultation (Citadel)
  • Response to public consultation (DTCC)
  • Response to public consultation (ISDA)
• Final Document in Sep 2021: Harmonisation of critical OTC derivatives data elements (other than UTI and UPI)- Revised: CDE Technical Guidance (version 2)